Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Depakene
02 1Depakine
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 519
2018 Revenue in Millions : 493
Growth (%) : 5
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 37
2019 Revenue in Millions : 43
Growth (%) : -13
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 30
2020 Revenue in Millions : 37
Growth (%) : -8
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 25
2021 Revenue in Millions : 30
Growth (%) : -18
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 19
2022 Revenue in Millions : 25
Growth (%) : -15
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 62
2016 Revenue in Millions : 70
Growth (%) : -11
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 48
2017 Revenue in Millions : 59
Growth (%) : -18%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 42
2018 Revenue in Millions : 49
Growth (%) : -15
LOOKING FOR A SUPPLIER?
